New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
09:18 EDTPGEM, ANFI, HIMX, DSW, GALE, YGE, NUAN, QIWI, FST, MDT, EXPEOn The Fly: Pre-market Movers
HIGHER: Amira Nature Foods (ANFI), up 30% after Q4 results top expectations... DSW (DSW), up 2.6% after upgraded at Goldman... Yingli Green Energy (YGE), up 3.4% after reaffirming its FY14 PVmodule shipment target... Nuance (NUAN), up 3% after WSJ reported yesterday that the company is looking into potential sale, Oppenheimer estimates that Nuance could be sold for $25-$30... Medtronic (MDT), up 2.8% after upgrades at Morgan Stanley, Credit Suisse, and RBC Capital... Forest Oil (FST), up 15% after Sabine Oil & Gas denies $850M bridge financing facility was pulled... Galena (GALE), up 5% after completing enrollment in GALE-301 Phase 2a trial... Expedia (EXPE), up 2.6% following upgrade at Susquehanna. LOWER: Ply Gem (PGEM), down 5.8% after downgraded at Goldman... Himax (HIMX), down 4.4% after downgraded at UBS... QIWI (QIWI), down 3.6% after 7.973M share Secondary priced at $40.00.
News For DSW;EXPE;NUAN;HIMX;MDT;YGE;ANFI;FST;GALE;PGEM;QIWI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
February 9, 2016
10:01 EDTMDTMedtronic: First patient treated with Valiant TAAA stent graft system in study
Subscribe for More Information
February 8, 2016
14:56 EDTMDTDexCom selloff overdone, based on misinformation, says Cowen
Subscribe for More Information
10:05 EDTANFIAmira Nature Foods management to meet with Oppenheimer
Subscribe for More Information
07:25 EDTGALEBiotech Industry Organization to hold a conference
Subscribe for More Information
07:13 EDTGALEGalena receives notice of allowance of U.S. patent for NeuVax
Galena Biopharma announced the United States Patent Office issued a Notice of Allowance for an additional U.S. patent application covering multiple uses of NeuVax. NeuVax is a peptide immunotherapy currently being evaluated for the prevention of cancer recurrence and is Galena's lead development agent in multiple ongoing and planned clinical trials. This patent will expand both the protection and the potential population of cancer patients NeuVax may address. Once issued, the patent will expire in 2028, not including any patent term extensions.
05:33 EDTHIMXHimax reports headquarters and facilities 'little affected' by Taiwan earthquake
Himax reported the company's headquarters and manufacturing facilities were little affected by the 6.4 magnitude earthquake which hit Tainan area at approximately 4:00 am local time, February 6. Himax Technologies also announced an immediate donation of NT$10 million to an earthquake relief fund by the Tainan Municipal Government.
February 5, 2016
09:12 EDTMDTMedtronic reports results from retrospective analysis of iPro2 Professional CGM
Subscribe for More Information
08:05 EDTMDTMedtronic receives FDA approval for MRI CRT-D
Medtronic announced that it has received FDA approval for the first and only magnetic resonance imaging, or MRI, conditional cardiac resynchronization therapy defibrillators, or CRT-Ds, for the treatment of heart failure. The Medtronic Amplia MRI Quad CRT-D SureScan and Compia MRI Quad CRT-D SureScan systems are approved for MRI scans on any part of the body without positioning restrictions. Now, patients in the U.S. who receive these devices, which help treat their heart failure and reduce their risk of sudden cardiac arrest, have access to MRI scans if and when they need them. Both CRT-D systems will be commercially available in the coming months.
08:00 EDTNUANNuance names Ken Siegel as Chief Legal Officer
Nuance Communications announced that it has appointed Ken Siegel as Chief Legal Officer to oversee Nuance's legal organization and operations. Bruce Bowden, who has served as interim General Counsel since 2015, will transition into a leadership role for Nuance's transformation initiative in addition to his current Corporate Strategy and Business Development leadership.
06:38 EDTYGEYingli Green Energy announces partnership with Iberdrola
Yingli Green Energy has recently signed an agreement with Iberdrola, for the new product "Smart Solar Iberdrola", the turnkey solar PV solution that Iberdrola has set up to its customers which offers the possibility to generate and consume their own electricity by installing this technology. Yingli will provide Iberdrola with its extensive portfolio of solar panels, experience and best resources including technical and human, for assembly work, configuration and monitoring of equipment performance, and preventive and corrective maintenance, to make sure the systems perform as safely and efficiently as possible.
February 4, 2016
06:14 EDTEXPETripAdvisor risk/reward now favorable into earnings, says Piper Jaffray
Piper Jaffray analyst Michael Olson says that following the significant underperformance of shares, the risk/reward for TripAdvisor (TRIP) is now favorable into the company's Q4 results. The slowdown in travel is already reflected into consensus estimates and concerns regarding the magnitude of the upcoming 2016 guide-down are overblown, Olson tells investors in a pre-earnings research note on the Online Content space. He reiterates an Overweight rating on the stock with a $120 price target. The analyst recommends avoiding Expedia (EXPE) and Priceline (PCLN) into the Q4 reports.
05:37 EDTHIMXHimax sees Q1 GAAP EPS 5.5c-7.5c, consensus 3c
Sees Q1 revenue to be down 1% to up 4%, consensus $168.36M. Sees Q1 gross margin to be around 25%.
05:36 EDTHIMXHimax 'mindful that 2016 will likely be a year of macro uncertainty'
Subscribe for More Information
05:35 EDTHIMXHimax reports Q4 non-GAAP EPS 4c, consensus 3c
Reports Q4 revenue $189M, consensus $171.94M. Compared to the previous quarter, large-sized panel driver sales increased by 22.9%, small and medium-sized panel driver sales decreased by 2.9% and non-driver sales increased by 10.5%. Revenue from large panel display drivers was $62.1M, revenue for small and medium-sized drivers came in at $81.9M, and revenues from non-driver businesses were $34M.
February 3, 2016
10:00 EDTQIWIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AIG (AIG) downgraded to Market Perform from Outperform at William Blair... Credit Acceptance (CACC) downgraded to Underperform at Raymond James... CIT Group (CIT) downgraded to Neutral from Buy at Citi... Cobalt (CIE) downgraded at Stifel... Cypress Energy (CELP) downgraded to Outperform from Strong Buy at Raymond James... Freeport McMoRan (FCX) downgraded on weak near-term outlook at Argus... Gastar Exploration (GST) downgraded to In-Line from Outperform at Imperial Capital... Intersil (ISIL) downgraded to Sell from Neutral at Citi... LyondellBasell (LYB) downgraded to Outperform from Top Pick at RBC Capital... Marriott (MAR) downgraded to Market Perform from Outperform at Wells Fargo... Microchip (MCHP) downgraded to Sell from Neutral at Goldman... Morgan Stanley (MS) downgraded to Underweight from Neutral at Atlantic Equities... Navios Maritime Partners (NMM) downgraded to Hold from Buy at Deutsche Bank... Peapack-Gladstone (PGC) downgraded to Hold from Buy at Sandler O'Neill... QIWI (QIWI) downgraded to Market Perform from Outperform at William Blair... STORE Capital (STOR) downgraded to Neutral from Buy at Ladenburg... Spark Energy (SPKE) downgraded to Neutral from Outperform at Baird... Stone Energy (SGY) downgraded to In-Line from Outperform at Imperial Capital... SunEdison Semiconductor (SEMI) downgraded to Sell from Neutral at Goldman... Teradyne (TER) downgraded to Neutral from Buy at Goldman... Texas Instruments (TXN) downgraded to Sell from Neutral at Goldman... UBS (UBS) downgraded to Sector Perform from Outperform at RBC Capital... Whiting Petroleum (WLL) downgraded on oil price outlook at Stifel... Xcel Energy (XEL) downgraded to Sell from Neutral at UBS... Xilinx (XLNX) downgraded to Buy from Conviction Buy at Goldman... Yahoo (YHOO) downgraded to Hold from Buy at Axiom.
09:05 EDTQIWIQIWI downgraded to Market Perform from Outperform at William Blair
William Blair analyst Robert Napoli downgraded QIWI to Market Perform after the company cut its FY15 outlook given the deteriorating macro environment in Russia.
06:35 EDTQIWIQIWI cuts FY15 adjusted revenue view to up 15%-16% vs. FY14
QIWI announced downward revisions to its previously announced full-year 2015 Adjusted Net Revenue guidance to a range of a 15% to 16% increase over 2014, down from its previous guidance of an 18% to 22% increase over 2014. In addition, QIWI is revising its previously announced full-year 2015 Adjusted Net Profit guidance to a range of a 16% to 18% increase over 2014, down from its previous guidance of an 18% to 22% increase over 2014.The downward revision in the Company's Adjusted Net Revenue guidance is primarily due to the continued economic recession in Russia as well as weak consumer demand pressured by high inflation and decreasing real income, which has resulted in performance that was lower than anticipated across certain market verticals, in particular e-commerce and money remittance. In the e-commerce market vertical, the Company expected to see a seasonal increase in demand from customers in accordance with trends observed in previous years that failed to materialize, particularly in physical e-commerce. In addition, the money remittance market vertical underperformed in terms of volumes as well as net revenue due to shifting migration trends and the termination of a few partnerships with counterparties and agents.The downward revision in the Company's Adjusted Net Profit guidance is primarily caused by the downward revision in the Company's Adjusted Net Revenue guidance and a substantial increase in bad debt expense compared to the full year ended December 31, 2014, resulting from an increase in reserves for receivables from several of QIWI's agents who have shown signs of financial instability.
February 1, 2016
10:08 EDTGALEHigh option volume stocks
High option volume stocks: NOK HLT NCLH DF GALE VMW DPS SYY SYMC PGR
10:02 EDTMDTMedtronic announced CE Mark, commercial launch for Resolute Onyx expansion
Medtronic announced the recent CE Mark and commercial launch for an expanded size matrix of the Resolute Onyx DES, a next generation drug-eluting stent that is now available in 4.5mm and 5.0mm diameter sizes. The CE Mark also approved several new product indications including treatment of left main vessels and small vessels. Many coronary vessels are large in diameter of which a sub-set are left main, and now physicians can treat these large vessels with optimally sized stents that provide appropriate drug concentration. Resolute Onyx is the first DES available in these sizes among major manufacturers, offering the broadest size matrix to optimize the treatment of complex clinical scenarios. The Resolute Onyx DES is not commercially available in the United States.
08:05 EDTMDTMedtronic acquires Bellco
Medtronic announced it acquired privately-held Bellco, a pioneer in hemodialysis treatment solutions. Bellco's portfolio bolsters Medtronic's legacy renal access business and will be a foundational component of the company's recently formed Renal Care Solutions business. The Bellco transaction is expected to meet Medtronic's long-term financial metrics for acquisitions. Medtronic expects the net impact from the transaction to be earnings neutral in FY16 and neutral to accretive to earnings thereafter.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use